Revenue | ₹4.73Cr |
Net Profits | ₹-1.49Cr |
Net Profit Margins | -31.50% |
Parmax Pharma Ltd’s revenue jumped 10.77% since last year same period to ₹4.73Cr in the Q4 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -24.92% fall in its revenue since last 3-months.
Parmax Pharma Ltd’s net profit fell -2.76% since last year same period to ₹-1.49Cr in the Q4 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -282.05% fall in its net profits since last 3-months.
Parmax Pharma Ltd’s net profit margin jumped 7.23% since last year same period to -31.50% in the Q4 2024-2025. On a quarterly growth basis, Parmax Pharma Ltd has generated -408.86% fall in its net profit margins since last 3-months.
The revenue for Parmax Pharma Ltd in the Q4 results 2024 was ₹4.73Cr.
The net profit for Parmax Pharma Ltd in the Q4 results 2024 was ₹-1.49Cr.
The net profit margin for Parmax Pharma Ltd in the Q4 results 2024 was -31.50%.
The revenue for Parmax Pharma Ltd in the Q4 results 2023 was ₹4.27Cr.
The net profit for Parmax Pharma Ltd in the Q4 results 2023 was ₹-1.45Cr.
The net profit margin for Parmax Pharma Ltd in the Q4 results 2023 was -33.96%.